Articles related to HYPERTENSION/BLOOD PRESSURE

Daily peppermint oil supplementation was associated with reduced systolic blood pressure and resting heart rate in a small placebo-controlled trial of adults with elevated or stage 1 hypertension.

The critical care nurse has a significant role to play in facilitating timely interventions for intracerebral hemorrhage patients, particularly regarding neurologic status changes and blood pressure control.

In two randomized phase‑3 trials, a single‑pill triple low‑dose antihypertensive combination achieved blood pressure reductions comparable to amlodipine and superior to losartan monotherapy over 8 weeks.

Sdamlo’s FDA approval offers a new oral solution option for delivering amlodipine, addressing administration challenges in patients who cannot tolerate tablets.

Baxdrostat significantly reduced seated systolic blood pressure compared to placebo in 796 patients, with placebo-adjusted reductions of 9.8 mmHg and 8.7 mmHg at the 2 mg and 1 mg doses respectively, without impacting cortisol levels.

A year‑in‑review article highlights major cardiovascular themes from 2025, including evolving approaches to hypertension, myocardial infarction management, and atrial fibrillation care.